We are live on ! Find out more
LCM

Lynwood Capital Management Portfolio holdings

AUM $16.9M
1-Year Est. Return 19.31%
This Fund
S&P 500
This Quarter Est. Return
+2.2%
1 Year Est. Return
-19.31%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$83.1M
AUM Growth
-$8.46M
Cap. Flow
-$7.26M
Cap. Flow %
-8.73%
Top 10 Hldgs %
36.24%
Holding
169
New
23
Increased
9
Reduced
18
Closed
38

Top Buys

Rank Stock Value
1
XFOR icon
X4 Pharmaceuticals
XFOR
+$3.4M
2
PYPL icon
PayPal
PYPL
+$3.2M
3
BCTX
Briacell Therapeutics
BCTX
+$1.87M
4
ATCO
Atlas Corp.
ATCO
+$1.54M
5
EOSE icon
Eos Energy Enterprises
EOSE
+$1.46M

Top Sells

Rank Stock Value
1
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$2.95M
2
ADBE icon
Adobe
ADBE
+$2.75M
3
LAAA
Lakeshore Acquisition I Corp. Ordinary Shares
LAAA
+$2.68M
4
CCXI
ChemoCentryx, Inc.
CCXI
+$2.58M
5
SNOW icon
Snowflake
SNOW
+$2.55M

Sector Composition

Rank Sector Weight
1 Financials 44.44%
2 Healthcare 15.83%
3 Industrials 10.35%
4 Technology 7.08%
5 Materials 5.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SOAR icon
76
Volato Group
SOAR
$8.89M
$255K 0.31%
1,000
– –
BMAC
77
DELISTED
Black Mountain Acquisition Corp.
BMAC
$255K 0.31%
25,000
– –
FSNB
78
DELISTED
Fusion Acquisition Corp. II
FSNB
$251K 0.3%
25,000
– –
SPCM
79
DELISTED
Sound Point Acquisition Corp I, Ltd Class A Ordinary Share
SPCM
$207K 0.25%
20,000
– –
INFN
80
DELISTED
Infinera Corporation Common Stock
INFN
$169K 0.2%
+25,000
New +$152K
ZCAR
81
DELISTED
Zoomcar
ZCAR
$141K 0.17%
7
– –
CITE
82
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
$137K 0.16%
13,199
– –
EONR
83
EON Resources
EONR
$25.4M
$106K 0.13%
10,350
– –
BIOS
84
DELISTED
BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS
$103K 0.12%
10,000
-15,000
-60% -$152K
TGR
85
DELISTED
Kimbell Tiger Acquisition Corporation
TGR
$103K 0.12%
10,000
– –
SOC icon
86
Sable Offshore Corp
SOC
$836M
$101K 0.12%
10,000
– –
ENER
87
DELISTED
Accretion Acquisition Corp
ENER
$101K 0.12%
10,000
– –
LTRN icon
88
Lantern Pharma
LTRN
$35.7M
$73K 0.09%
+12,000
New +$60.1K
IMMX icon
89
Immix Biopharma
IMMX
$712M
$58K 0.07%
+25,000
New +$33.3K
ONCY
90
Oncolytics Biotech
ONCY
$96.3M
$41K 0.05%
+25,000
New +$38K
MTAL
91
DELISTED
Metals Acquisition
MTAL
$27K 0.03%
2,600
– –
DCRDW
92
DELISTED
Decarbonization Plus Acquisition Corporation IV Warrant
DCRDW
$20K 0.02%
35,000
-5,000
-13% -$2.92K
NAAC
93
DELISTED
North Atlantic Acquisition Corporation Class A Ordinary Share
NAAC
$18K 0.02%
1,726
– –
SLND.WS icon
94
Southland Holdings Warrants
SLND.WS
$1.28M
$14K 0.02%
30,000
– –
CINGW icon
95
Cingulate Inc Warrants
CINGW
$25.7K
$11K 0.01%
50,000
– –
TYGOW
96
DELISTED
Tigo Energy, Inc. Warrant
TYGOW
$11K 0.01%
45,000
-5,000
-10% -$584
DECAW
97
DELISTED
Denali Capital Acquisition Corp. Warrant
DECAW
$5K 0.01%
104,500
– –
RFACR
98
DELISTED
RF Acquisition Corp. Rights
RFACR
$5K 0.01%
55,000
– –
QTEXW
99
DELISTED
QTREX Quantum Warrant
QTEXW
$4K ﹤0.01%
20,000
– –
LIVBW
100
DELISTED
LIV Capital Acquisition Corp. II Warrants
LIVBW
$4K ﹤0.01%
39,390
– –
2 3
4
5 6

Similar funds

PA
Pantechnicon Advisors London, United Kingdom $18.4M AUM 26.45% 1-Year Est. Return
PML
Prime Movers Lab Jackson, Wyoming $13.5M AUM 0% 1-Year Est. Return
OPPTF
OPSEU Pension Plan Trust Fund Toronto, Ontario, Canada $22.4M AUM 25.54% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
SCP
Syntal Capital Partners Midland, Texas $10M AUM 35.51% 1-Year Est. Return
NCM
Newfoundland Capital Management Sao Paulo, Brazil $9.47M AUM 21.24% 1-Year Est. Return
MA
Macellum Advisors New York $7.23M AUM 23.78% 1-Year Est. Return
OMC
Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return

Lynwood Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Lynwood Capital Management held 169 positions worth $83.1M, down 9.2% from $91.6M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Lynwood Capital Management withdrew a net $7.26M in Q4 2022, closing 38 positions and reducing 18 holdings. Its most notable exit was VanEck Junior Gold Miners ETF, an estimated $2.95M position sold in full.

By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 48% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Lynwood Capital Management opened a new position in X4 Pharmaceuticals worth $2.14M.

  • Lynwood Capital Management's largest Q4 2022 buy was X4 Pharmaceuticals: 71,837 shares worth $2.14M.
  • Lynwood Capital Management added most to Briacell Therapeutics in Q4 2022, an estimated $1.87M increase.
  • Lynwood Capital Management's biggest Q4 2022 reduction was Mountain & Co. I Acquisition Corp. Class A Ordinary Shares, cutting an estimated $464K.
  • Lynwood Capital Management fully exited VanEck Junior Gold Miners ETF in Q4 2022, selling an estimated $2.95M.
  • Lynwood Capital Management's ten largest holdings make up 36% of its $83.1M portfolio in Q4 2022.
  • Lynwood Capital Management opened 23 new positions and closed 38 in Q4 2022.
  • Lynwood Capital Management's portfolio value fell 9.2% quarter-over-quarter to $83.1M.

Based on Lynwood Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.